Literature DB >> 20804453

Substrate path in the AcrB multidrug efflux pump of Escherichia coli.

Fasahath Husain1, Hiroshi Nikaido.   

Abstract

A major tripartite multidrug efflux pump of Escherichia coli, AcrAB-TolC, confers resistance to a wide variety of compounds. The drug molecule is captured by AcrB probably from the periplasm or the periplasm/inner membrane interface, and is passed through AcrB and then TolC to the medium. Currently, there exist numerous crystallographic and mutation data concerning the regions of AcrB and its homologues that may interact with substrates. Starting with these data, we devised fluorescence assays in whole cells to determine the entire substrate path through AcrB. We tested 48 residues in AcrB along the predicted substrate path and 25 gave positive results, based on the covalent labelling of cysteine residues by a lipophilic dye-maleimide and the blocking of Nile red efflux by covalent labelling with bulky maleimide reagents. These residues are all located in the periplasmic domain, in regions we designate as the lower part of the large external cleft, the cleft itself, the crystallographically defined binding pocket, and the gate between the pocket and the funnel. Our observations suggest that the substrate is captured in the lower cleft region of AcrB, then transported through the binding pocket, the gate and finally to the AcrB funnel that connects AcrB to TolC.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804453      PMCID: PMC3008161          DOI: 10.1111/j.1365-2958.2010.07330.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  41 in total

1.  Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump.

Authors:  Edward W Yu; Gerry McDermott; Helen I Zgurskaya; Hiroshi Nikaido; Daniel E Koshland
Journal:  Science       Date:  2003-05-09       Impact factor: 47.728

2.  AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex.

Authors:  Elena B Tikhonova; Helen I Zgurskaya
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

3.  The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?

Authors:  H Nikaido
Journal:  Drug Resist Updat       Date:  1998       Impact factor: 18.500

4.  Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

Authors:  Jürgen A Bohnert; Sabine Schuster; Eva Fähnrich; Rainer Trittler; Winfried V Kern
Journal:  J Antimicrob Chemother       Date:  2006-10-24       Impact factor: 5.790

5.  A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.

Authors:  Edward W Yu; Julio R Aires; Gerry McDermott; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

6.  Entry into and release of solvents by Escherichia coli in an organic-aqueous two-liquid-phase system and substrate specificity of the AcrAB-TolC solvent-extruding pump.

Authors:  N Tsukagoshi; R Aono
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

7.  Structural mechanism of the simultaneous binding of two drugs to a multidrug-binding protein.

Authors:  Maria A Schumacher; Marshall C Miller; Richard G Brennan
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

8.  Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

9.  Spectrofluorometric studies of the lipid probe, nile red.

Authors:  P Greenspan; S D Fowler
Journal:  J Lipid Res       Date:  1985-07       Impact factor: 5.922

10.  CAVER: a new tool to explore routes from protein clefts, pockets and cavities.

Authors:  Martin Petrek; Michal Otyepka; Pavel Banás; Pavlína Kosinová; Jaroslav Koca; Jirí Damborský
Journal:  BMC Bioinformatics       Date:  2006-06-22       Impact factor: 3.169

View more
  36 in total

1.  Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop.

Authors:  Thomas Eicher; Hi-jea Cha; Markus A Seeger; Lorenz Brandstätter; Jasmin El-Delik; Jürgen A Bohnert; Winfried V Kern; François Verrey; Markus G Grütter; Kay Diederichs; Klaas M Pos
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

2.  Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.

Authors:  Ketaki Soparkar; Alfred D Kinana; Jon W Weeks; Keith D Morrison; Hiroshi Nikaido; Rajeev Misra
Journal:  J Bacteriol       Date:  2015-08-03       Impact factor: 3.490

3.  Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance.

Authors:  Errett C Hobbs; Xuefeng Yin; Brian J Paul; Jillian L Astarita; Gisela Storz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

4.  Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB.

Authors:  Alfred D Kinana; Attilio V Vargiu; Hiroshi Nikaido
Journal:  Biochemistry       Date:  2013-11-11       Impact factor: 3.162

5.  A fluorescent microplate assay quantifies bacterial efflux and demonstrates two distinct compound binding sites in AcrB.

Authors:  Ramkumar Iyer; Annette Ferrari; R Rijnbrand; Alice L Erwin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

6.  Vestibules are part of the substrate path in the multidrug efflux transporter AcrB of Escherichia coli.

Authors:  Fasahath Husain; Mihir Bikhchandani; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2011-08-19       Impact factor: 3.490

Review 7.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

8.  Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump.

Authors:  Bryan D Schindler; Diixa Patel; Susan M Seo; Glenn W Kaatz
Journal:  J Bacteriol       Date:  2012-11-21       Impact factor: 3.490

9.  Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.

Authors:  Attilio V Vargiu; Paolo Ruggerone; Timothy J Opperman; Son T Nguyen; Hiroshi Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

10.  Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB.

Authors:  Sabine Schuster; Martina Vavra; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.